Capienda is developing an advanced system (novel assay chemistry + bioanalytical instrument) to accelerate drug discovery in the pharmaceutical industry.
METHODS AND SYSTEMS FOR HIGH-THROUGHPUT KINETIC ANALYSIS OF LIGAND-RECEPTOR INTERACTIONS
US Patent Applications 63/676,831 and 63/765,075 (unpublished).
Capienda’s drug delivery technology is designed to target disease-relevant cells (while avoiding normal cells) and engages previously un-druggable targets.
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES. Publication No. WO/2019/195179 (International Application No. PCT/US2019/025,207)